Moderna noted the FDA did not identify any specific safety concerns with the vaccine and that the rejection was inconsistent ...
The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu ...
Moderna said the move is inconsistent with previous feedback from the FDA on the experimental influenza shot, called ...
The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday ...
The decision follows a pattern of policy shifts, including the rollback of COVID-19 recommendations and cancellation of mRNA ...
Moderna said on Tuesday the U.S. Food and Drug Administration will not review its approval application for its influenza ...
The Food and Drug Administration on Tuesday took steps toward banning BHA, a food additive used in processed foods such as meats and bread ...
The Food and Drug Administration (FDA) announced Tuesday that it is reviewing whether butylated hydroxyanisole (BHA) is safe ...
The Food and Drug Administration is undertaking a review of the chemical preservative butylated hydroxyanisole to determine ...
The U. Food and Drug Administration will not review Moderna's approval application for its influenza vaccine, the company said on Tuesday, sending its shares down 8% in extended trading.
The decision, which shocked company officials, comes as the FDA says it will take a stricter approach to federal vaccine approvals.
FDA approves pembrolizumab with chemotherapy for platinum-resistant ovarian cancer, showing significant survival benefits in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results